1 / 31

Chapter 22 Pneumothorax

Chapter 22 Pneumothorax. CL. GA. DD. Figure 22-1. Right-side pneumothorax. GA, Gas accumulation; DD, depressed diaphragm; CL, collapsed lung. Inset, Atelectasis, a common secondary anatomic alteration of the lungs. Anatomic Alterations of the Lungs. Lung collapse Atelectasis

ssantangelo
Download Presentation

Chapter 22 Pneumothorax

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 22 Pneumothorax CL GA DD Figure 22-1. Right-side pneumothorax. GA, Gas accumulation; DD, depressed diaphragm;CL, collapsed lung. Inset, Atelectasis, a common secondary anatomic alteration of the lungs.

  2. Anatomic Alterations of the Lungs • Lung collapse • Atelectasis • Chest wall expansion • Compression of the great veins and decreased cardiac venous return

  3. Etiology—3 Ways • From the lungs through a perforation of the visceral pleura • From the surrounding atmosphere through a perforation of the chest wall and parietal pleura or, rarely, through an esophageal fistula or a perforated abdominal viscus • From gas-forming microorganisms in an empyema in the pleural space (rare)

  4. Pneumothorax ClassificationsGeneral Terms • Closed pneumothorax • Open pneumothorax • Tension pneumothorax

  5. Pneumothorax ClassificationsBased on Origin • Traumatic pneumothorax • Spontaneous pneumothorax • Iatrogenic pneumothorax

  6. Figure 22-3. Closed (tension) pneumothorax produced by a chest wall wound.

  7. Figure 22-4. Pneumothorax produced by a rupture in the visceral pleura that functions as a check valve.

  8. Spontaneous Pneumothorax

  9. Iatrogenic Pneumothorax

  10. Overview of the Cardiopulmonary Clinical Manifestations Associated with PNEUMOTHORAX The following clinical manifestations result from the pathophysiologic mechanisms caused (or activated) by Atelectasis (see Figure 9-7)—the major anatomic alterations of the lungs associated with pneumothorax (see Figure 22-1).

  11. Figure 9-7. Atelectasis clinical scenario.

  12. Clinical Data Obtained at the Patient’s Bedside Vital signs • Increased respiratory rate • Stimulation of peripheral chemoreceptors • Other possible mechanisms • Decreased lung compliance • Activation of the deflation receptors • Activation of the irritant receptors • Stimulation of the J receptors • Pain/anxiety • Increased heart rate, cardiac output, blood pressure

  13. Figure 22-5. Venous admixture in pneumothorax.

  14. Clinical Data Obtained at the Patient’s Bedside • Cyanosis • Chest assessment findings • Hyperresonant percussion note over the pneumothorax • Diminished breath sounds over the pneumothorax • Tracheal shift • Displaced heart sounds • Increased thoracic volume on the affected side • Particularly in tension pneumothorax

  15. Figure 22-6. Because the ratio of extrapulmonary gas to solid tissue increases in a pneumothorax, hyperresonant percussion notes are produced over the affected area.

  16. Figure 22-7. Breath sounds diminish as gas accumulates in the intrapleural space.

  17. Figure 22-8. As gas accumulates in the intrapleural space, the chest diameter increases on the affected side in a tension pneumothorax.

  18. Clinical Data Obtained from Laboratory Tests and Special Procedures

  19. Pulmonary Function Study: Lung Volume and Capacity Findings VT RV FRC TLC N or    VC IC ERV RV/TLC%    N

  20. Arterial Blood Gases Small Pneumothorax • Acute alveolar hyperventilation with hypoxemia pH PaCO2 HCO3- PaO2 (Slightly)

  21. Time and Progression of Disease Disease Onset Alveolar Hyperventilation 100 90 Point at which PaO2 declines enough to stimulate peripheral oxygen receptors 80 70 60 PaO2 PaO2 or PaCO2 50 40 30 PaCO2 20 10 0 Figure 4-2. PaO2 and PaCO2 trends during acute alveolar hyperventilation.

  22. Arterial Blood Gases Large Pneumothorax • Acute ventilatory failure with hypoxemia pH PaCO2 HCO3- PaO2  (Slightly)

  23. Time and Progression of Disease Disease Onset Alveolar Hyperventilation Acute Ventilatory Failure 100 Point at which disease becomes severe and patient begins to become fatigued 90 Point at which PaO2 declines enough to stimulate peripheral oxygen receptors 80 70 PaCO2 Pa02 or PaC02 60 50 40 30 PaO2 20 10 0 Figure 4-7. PaO2 and PaCO2 trends during acute ventilatory failure.

  24. Oxygenation Indices QS/QT DO2 VO2 C(a-v)O2  Normal (severe) O2ER SvO2 

  25. Hemodynamic Indices (Large Pneumothorax) CVP RAP PAPCWP  CO SV SVICI  RVSWI LVSWI PVRSVR 

  26. Radiologic Findings Chest radiograph • Increased translucency • Mediastinal shift to unaffected side in tension pneumothorax • Depressed diaphragm • Lung collapse • Atelectasis

  27. Figure 22-9. Left-sided pneumothorax (arrows). Note the shift of the heart and mediastinum to the right away from the tension pneumothorax.

  28. B A Figure 22-10. A, Development of a small tension pneumothorax in the lower part of the right lung (arrow). B, The same pneumothorax 30 minutes later. Note the shift of the heart and mediastinum to the left away from the tension pneumothorax. Also note the depression of the right hemidiaphragm (arrow).

  29. General Management of Pneumothorax • >20%—gas should be evacuated • Negative pressure—5 to 12 cm H2O • Should not exceed negative 12 cm H2O

  30. General Management of Pneumothorax Respiratory care treatment protocols • Oxygen therapy protocol • Hyperinflation therapy protocol • Mechanical ventilation protocol

  31. General Management of Pneumothorax PLEURODESIS • Chemical or medication injected into the chest cavity • Talc • Tetracycline • Bleomycin sulfate • Produces inflammatory reaction between lungs and inner chest cavity • Causes lung to stick to chest cavity

More Related